|
Post by svart on Apr 1, 2020 11:59:07 GMT -6
My speculative guesstimate is that the fatality rate, will eventually average out (factoring in asymtomatic cases)... To around .5 to .6%. Chris It's currently about 0.6% for deaths from positively identified infections. Since smaller studies like the new Icelandic study are showing 50%+ asymptomatic cases, the actual death rate will be much lower than we currently know once any kind of verification of asymptomatic infections is done using antibody tests. " If one assumes that the number of asymptomatic or minimally symptomatic cases is several times as high as the number of reported cases, the case fatality rate may be considerably less than 1%. This suggests that the overall clinical consequences of Covid-19 may ultimately be more akin to those of a severe seasonal influenza (which has a case fatality rate of approximately 0.1%) or a pandemic influenza (similar to those in 1957 and 1968) rather than a disease similar to SARS or MERS, which have had case fatality rates of 9 to 10% and 36%, respectively.2" www.nejm.org/doi/full/10.1056/NEJMe2002387?fbclid=IwAR1z1VgigC7spGBUhu6cQ6AKcKiQ2oaSOCl61w6JK-myh__joMaEu9RJ9VM
|
|
|
Post by drbill on Apr 1, 2020 13:30:19 GMT -6
My speculative guesstimate is that the fatality rate, will eventually average out (factoring in asymtomatic cases)... To around .5 to .6%. Chris Are you an epidemiologist?
|
|
|
Post by chessparov on Apr 1, 2020 13:50:57 GMT -6
Well I did have an "epidemy", about all this! Chris
|
|
|
Post by matt@IAA on Apr 1, 2020 16:53:11 GMT -6
My speculative guesstimate is that the fatality rate, will eventually average out (factoring in asymtomatic cases)... To around .5 to .6%. Chris It's currently about 0.6% for deaths from positively identified infections. Since smaller studies like the new Icelandic study are showing 50%+ asymptomatic cases, the actual death rate will be much lower than we currently know once any kind of verification of asymptomatic infections is done using antibody tests. " If one assumes that the number of asymptomatic or minimally symptomatic cases is several times as high as the number of reported cases, the case fatality rate may be considerably less than 1%. This suggests that the overall clinical consequences of Covid-19 may ultimately be more akin to those of a severe seasonal influenza (which has a case fatality rate of approximately 0.1%) or a pandemic influenza (similar to those in 1957 and 1968) rather than a disease similar to SARS or MERS, which have had case fatality rates of 9 to 10% and 36%, respectively.2" www.nejm.org/doi/full/10.1056/NEJMe2002387?fbclid=IwAR1z1VgigC7spGBUhu6cQ6AKcKiQ2oaSOCl61w6JK-myh__joMaEu9RJ9VMTwo key points there. One is "if one assumes..." the other is "more akin to". Closer to 0.1% than 10% or 36% is anything below 5%. Look, that paper was published online on Feb 28. Somehow the media is just discovering it. The current estimate being used by the administration is around 0.66% - that's the one published in the Lancet the othe rday, but was pre-print available in mid March and was used for the baseline case in the Imperial College study. That's an estimated infection fatality ratio which includes asymptomatics, not a case fatality ratio which is symptomatic observed only.
|
|
|
Post by chessparov on Apr 1, 2020 19:13:00 GMT -6
One of my best/childhood friends "dodged a bullet", when his teenage daughter (right before the Stay Home policy/CA)... Ended up having to stay in (effective) quarantine elsewhere, for just over two weeks (she's fine now).
We're 95%+ sure, from the symptoms, she had it. Fortunately, the Family she stayed with, also "stayed in", to make sure they were all OK, during the whole time.
But he has severe asthma, and this would've been life threatening, if he caught it. Hoping this will be "as close as it gets", with any of my loved ones! Chris
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Apr 1, 2020 20:06:11 GMT -6
fyi: www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6This is the visualization of John Hopkins University. Their numbers are basis of european decisions on how to proceed. Germany has extended the social distance rule (which to break is actually a crime) for 2 more weeks, it is most likely to extend a lot longer though. Btw. Germany tests a lot more (per person) than many countries incl. the US. So this has to be considered to set number in relation ... The most disturbing numbers are the numbers of fatal cases, and IMHO - to consider the reduction of these as highest priority is a matter of beeing human. I know, there are other opinions on this. Therefore I explicitly said "in my opinion". Just to be totally clear on that. I do not post this to start another political flame war on how to proceed in the best way.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Apr 1, 2020 20:39:02 GMT -6
Despite the fact,that the measurements in Germany seem to work for our countries topology/infrastructure/population, I have information from the hospitals in our federal state, that they work on the limit of everything. Some in 24h shifts (24h work/24h free) and they consider the actual situation as the worst since WW2, i.e. unprecedented in their lifetime. My brother worked in a hospital for over 30 yrs., the last years in intensive care, and has many friends in the regional healthcare system, and not only the workload they experience now is disturbing, so is the actual symptomatic of those that need hospitalization. They are not faint of the heart, the guys that work in hospitals for decades, and they have experience with very ugly infectional deseases like meningococcus etc, on a regular basis, but the contagious character combined with the seriousness of those cases does seemingly disturb everyone who directly has to deal with it ... Let's hope this nightmare is over as soon as it gets, no matter what it takes ... (again, personal statement, YMMV)
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Apr 1, 2020 20:54:17 GMT -6
Here a direct datacenter visualization about the curves of new cases, with the momentary conclusion about "flattening the curve". I just post the link for information, it gets actualized as soon as new numbers appear: coronavirus.jhu.edu/data/new-cases
|
|
|
Post by the other mark williams on Apr 1, 2020 21:26:06 GMT -6
My speculative guesstimate is that the fatality rate, will eventually average out (factoring in asymtomatic cases)... To around .5 to .6%. Chris well, the CFR could (and likely will) look quite different in different regions, though, right? The CFR in Italy is quite different than the CFR in Germany, for instance (at least as of the most current data). I wouldn’t be surprised if we see the same kinds of health disparities here: say, Louisiana vs. California or Wisconsin. There are really (at least) two crises here: one is clinical and the other is public health. For all kinds of reasons, the US has a wider health disparity across its population. I imagine we may see that play out. EDIT: Apologies if the above sounded presumptive in any way: I’m not trying to suggest you hadn’t thought about this, chessparov
|
|
|
Post by chessparov on Apr 1, 2020 23:30:19 GMT -6
Not at all Mark! My thinking is in alignment with yours. The fact that some of the health workers who had "boosted" immune systems, from regularly being exposed to patients... Then being in a "hot spot" like Italy, and dying. THAT makes a big impact with me, as I have a strong immune system myself. Which was from teaching tons of kids per year. Just hearing a small amount of the heart rending stories related to this, is very tough. Chris
|
|
|
Post by Johnkenn on Apr 3, 2020 8:28:10 GMT -6
That’s something I wonder about - obesity/pre-diabetes/diabetes, etc is more prevalent in the South and Midwest. You wonder whether we will see higher instances of hospitalization over the next few weeks in those places. On the other hand - www.livescience.com/death-rate-lower-than-estimates.htmlThe coronavirus mortality rate might be lower than previously thought, according to a new study. A group of researchers analyzed data from China and found that the overall mortality rate of COVID-19 was 1.38%. But if they adjusted for cases that likely went unaccounted for due to their mild or asymptomatic nature, the overall mortality rate decreased to around 0.66%, they reported on March 30 in journal The Lancet Infectious Diseases. Past estimates had placed the mortality rate somewhere between 2% and 3.4% in Wuhan, China where the outbreak first began, according to a previous Live Science report. A recent study published in the journal Nature Medicine had found that the death rate in the city — without including those who were likely asymptomatic — was around 1.4%. Related: 13 coronavirus myths busted by science In this new study, to figure out the true "infection fatality ratio" — the mortality rate that includes the people with mild cases who may have not been counted before — the researchers looked to data from people who were flown back to their various countries from Wuhan, China during the outbreak. Those repatriated people were given PCR tests — tests which detect specific genetic material within the virus, according to a previous Live Science report. They also used data from Diamond Princess cruise ship passengers who also received PCR testing. Since these tests were given to people who didn't necessarily show symptoms, the researchers were able to estimate the prevalence of such cases. Consistent with previous research, the new study also found that the death rate varied greatly by age. While the death rate was around 0.0016% in 0 to 9-year-olds, it increased to about 7.8% for people who were age 80 and above. The researchers also found that nearly 1 in 5 people over the age of 80 infected with COVID-19 were likely to require hospitalization whereas only 1% of people under 30 were likely to be hospitalized. "Estimating the case fatality ratio for COVID-19 in real time during its epidemic is very challenging," Shigui Ruan, a professor in the department of mathematics at The University of Miami wrote in an accompanying commentary. But the infection fatality ratio "is a very important piece of data that will help to guide the response from various government and public health authorities worldwide." The case fatality ratios will vary slightly from county to country, based on differences in the policies and measures put in place to control the outbreak, he added. In any case, these mortality rate estimates are still much higher than that of the seasonal flu, which kills around 0.1% of people who are infected. "Even though the fatality rate is low for younger people, it is very clear that any suggestion of COVID-19 being just like influenza is false," he wrote. For those between the ages of 20 to 29, for instance, the chance of dying from SARS-CoV-2 is 33 times higher than the odds of dying from seasonal influenza, he wrote.
|
|
|
Post by matt@IAA on Apr 3, 2020 9:37:15 GMT -6
The 0.66% estimate is by the team lead by Verity at Imperial College. It was just published in the Lancet, but was available pre-print in early March and was the basis for the Imperial College paper that had the unlikely do-nothing scenario of ~2 million deaths in the US.
The tie-in to obesity, age, and diabetes had a researcher thinking there may be some viral attack on heme, on the blood itself. All of the risk factors we see result in higher blood sugar, so perhaps this is part of the deadliness.
|
|
|
Post by Johnkenn on Apr 3, 2020 9:40:26 GMT -6
The 0.66% estimate is by the team lead by Verity at Imperial College. It was just published in the Lancet, but was available pre-print in early March and was the basis for the Imperial College paper that had the unlikely do-nothing scenario of ~2 million deaths in the US. The tie-in to obesity, age, and diabetes had a researcher thinking there may be some viral attack on heme, on the blood itself. All of the risk factors we see result in higher blood sugar, so perhaps this is part of the deadliness. I read that early Imperial report and as far as I can tell, they still estimated @100k deaths even with mitigation.
|
|
|
Post by Johnkenn on Apr 3, 2020 10:00:29 GMT -6
www.rnz.co.nz/national/programmes/checkpoint/audio/2018740956/pandemic-scientist-makes-breakthrough-on-covid-19-curePandemic' scientist makes breakthrough on Covid-19 cure Scientists around the world have been racing to develop treatments, cures and a vaccine for Covid-19, and are getting closer by the day. Jacob Glanville - one of the stars of Netflix documentary Pandemic - runs Distributed Bio, which has been working to find an antibody therapy. On Monday he tweeted that a development was imminent. "I'm happy to report that my team has successfully taken five antibodies that back in 2002 were determined to bind and neutralise, block and stop the SARS virus," Dr Glanville told Checkpoint. "We've evolved them in our laboratory, so now they very vigorously block and stop the SARS-CoV-2 [Covid-19] virus as well. "This makes them suitable medicines that one could use once they've gone through human testing to treat the virus," Dr Glanville said. "The new virus is a cousin of the old SARS. So what we've done is we've created hundreds of millions of versions of those antibodies, we've mutated them a bit, and in that pool of mutated versions, we found versions that cross them over. "So now we know they bind on the same spot as the new virus, Covid-19. "It binds the spot that the virus uses to gain entry into your cells. It blocks that. "At this point we know it binds the same spot extremely tightly with high affinity. The next step is we send the antibodies to the military, and they will directly put those on the virus and show that it blocks its ability to infect cells." Dr Glanville told Checkpoint the military deals with the virus itself as he does not want Covid-19 or SARS in his laboratory. "The other nice thing about it is you want the stamp of approval of a government military to independently test your work. This is one of the foundations of good science. "Antibodies are attractive because you can give them to a patient right when they're in the hospital like an antiviral. You can also give them to doctors, you could give them to the elderly people to prevent them from getting sick." There are a couple of groups around the world who have been working on developing antibodies, he said. "Part of the reason we think we're moving pretty fast is that instead of starting from scratch discovering an antibody, we went to these existing antibodies that were already extremely well characterised against SARS. And we've adapted them. So we're piggybacking on two years of research. "It's sort of like a short-term vaccine, except it works immediately. "A vaccine could take six to eight weeks to take effect, where this will take effect within 20 minutes. You could give it to a patient who's sick, experiencing Covid-19, then within 20 minutes of receiving the shot, their body is flooded with those antibodies. "Those antibodies will surround and stick all over a virus and make it so it's no longer infectious." The disadvantage compared to a vaccine is that a vaccine might give you a year or multiple years of protection, Dr Glanville said. Antibodies will only give protection for eight to 10 weeks. The military will test the antibodies against Covid-19, and another laboratory will start tests to make sure the medicine is safe for humans. If those are successful, production of the antibodies have to be scaled up. "We use very exacting manufacturing standards called GMP for making a medicine, and that can take multiple months," Dr Glanville said. "Once that material is ready we go into a human trial. That's a ... trial where you give it to a series of 400 to 600 people who are in hospitals experiencing symptoms, and then you watch over the next five to 10 days to see whether it helped or not." He said he and his colleagues are doing everything they can to speed up the process, but it does take time. "We have saved potentially years of research by piggybacking on the SARS antibodies and our technology is very good at engineering these things to cross and we've succeeded in doing that. "The next step, the big-time consuming part, is the GMP manufacturer. Traditionally, that takes nine to 12 months, obviously, we can't wait that long. So we've worked with two different partners to try to accelerate that to take a few months but that does take time and there's really no way around." "Assuming that we're able to complete our study, at the end of summer… and it looks good, then we would use something called compassionate use. "This is was used in the Ebola crisis. And it's been used in other cases where if you have something that's effective, and there's no other good medicine, you can begin releasing it to the world for use prior to going through all the approval process. "That could be as early as September. Unfortunately, that's also as far away as September. "So that's as fast as we can conceive of having this medicine widely available." He told Checkpoint it is essential for his laboratory that everyone gains access to the medicine. He said they are talking to the European Commission and there is interest in Asia. "My feeling is that we should also in anticipation that that study looks good… we should start scaling up a lot more doses, hundreds of thousands to millions for the next step."
|
|
|
Post by Johnkenn on Apr 3, 2020 10:25:31 GMT -6
|
|
|
Post by svart on Apr 3, 2020 10:29:52 GMT -6
As much good news as it is, it seems so many are dead set to disbelieve it and fight to make others believe it's much worse than it really is. I have no idea why.
|
|
|
Post by matt@IAA on Apr 3, 2020 10:36:33 GMT -6
I read that early Imperial report and as far as I can tell, they still estimated @100k deaths even with mitigation. For the UK, the do-nothing was 500k and shutdown was 5-40k. If you lever that up for the US estimates, do-nothing was 2 million, shutdown 20-200k. There were two papers. One was Verity's estimate of how severe it is. That was used in the Imperial report with the 0.66%. Then, it was published in the Lancet. The media is acting like Verity's paper somehow invalidates the Imperial report by having a "new" lower fatality rate, when in reality it was one of the key pieces of the original study. They're confused by the lag in publication.
|
|
|
Post by matt@IAA on Apr 3, 2020 10:42:53 GMT -6
The real problem here is the media watching models with *zero* comprehension of their use or assumptions, combined with total fear-mongering and sensationalism.
The Imperial study is a great case. You generate a baseline, then you see what you can do to that baseline by taking certain actions. It's like, if do-nothing costs $100 but I can do option A and save $40 and option B and save $60, then even if do-nothing actually costs $50, you can expect to save $20 and $30 respectively. Obviously they want to make the baseline case as accurate as possible, but you can only roll with the information you've got. The paper clearly states the assumptions, the likelihood or reliability of the base case (not very high!) and says they'll update as they can. None of that is reported. Instead, the media portrays the baseline case as the estimate.
The UW study on the other hand is using information from around the world to try to anticipate hospital load based on observed cases. There are some problems with this - the main one being we aren't testing sufficiently to know. Houston has been reporting that NO ONE is being tested unless they're being admitted in our county hospital. And, tests are running up to 14 days behind. That means you might have a death before the hospital number reflects reality. Unsurprisingly, the UW model is actually under-anticipating deaths right now. The UW model is to inform local officials of what to expect.
It's easier, though, to spread FUD on twitter (you can spread FUD by sensationalism and fear as well as encouraging doubt and unrest!!!)
|
|
|
Post by ragan on Apr 3, 2020 10:54:40 GMT -6
The merchants of politically tribal confirmation bias are indeed working overtime to capitalize on the pandemic. People give enormous benefit of the doubt to whoever says something soothing to their own persuasion. Everyone is guilty of it to some extent but when there’s this much fear and confusion and the consequences are on this scale the effect is extra potent.
|
|
|
Post by matt@IAA on Apr 3, 2020 10:59:53 GMT -6
Yeah. Maybe the real lesson here is that transparency on these kind of models should be discouraged. Maybe the public-facing ones should be nondimensionalized. :/
|
|
|
Post by svart on Apr 3, 2020 11:16:37 GMT -6
The merchants of politically tribal confirmation bias are indeed working overtime to capitalize on the pandemic. People give enormous benefit of the doubt to whoever says something soothing to their own persuasion. Everyone is guilty of it to some extent but when there’s this much fear and confusion and the consequences are on this scale the effect is extra potent. Which is exactly why I don't understand why so many who are intent on brushing away the better news that's starting to come out. I believe it's a way for people to dismiss their rush to fear, as if to say that their over-reaction was indeed warranted and that they're not actually duped by media sensationalism.
|
|
|
Post by the other mark williams on Apr 3, 2020 11:20:16 GMT -6
Yeah. Maybe the real lesson here is that transparency on these kind of models should be discouraged. Maybe the public-facing ones should be nondimensionalized. :/ ...and maybe we should listen to people like the Dr. Faucis of the world and then turn off the damn news. Regardless of the supposed bias of whatever news resource we consume, we must remember that they are trying to sell virtual newspapers and ads based on number of eyeballs. They have a near-zero need to report numbers and forecasts and scientific papers accurately. That’s not by and large what attracts viewers.
|
|
|
Post by matt@IAA on Apr 3, 2020 11:22:24 GMT -6
A local bishop told his diocese to limit their consumption of epidemic news to 15 minutes a day. Probably good advice.
|
|
|
Post by svart on Apr 3, 2020 11:25:30 GMT -6
Yeah. Maybe the real lesson here is that transparency on these kind of models should be discouraged. Maybe the public-facing ones should be nondimensionalized. :/ ...and maybe we should listen to people like the Dr. Faucis of the world and then turn off the damn news. Regardless of the supposed bias of whatever news resource we consume, we must remember that they are trying to sell virtual newspapers and ads based on number of eyeballs. We should. Dr fauci is one of the authors that surmises this could ultimately be no worse that a bad flu if we could figure out how many were actually infected, but asymptomatic.
|
|
|
Post by ragan on Apr 3, 2020 11:30:15 GMT -6
The merchants of politically tribal confirmation bias are indeed working overtime to capitalize on the pandemic. People give enormous benefit of the doubt to whoever says something soothing to their own persuasion. Everyone is guilty of it to some extent but when there’s this much fear and confusion and the consequences are on this scale the effect is extra potent. Which is exactly why I don't understand why so many who are intent on brushing away the better news that's starting to come out. I believe it's a way for people to dismiss their rush to fear, as if to say that their over-reaction was indeed warranted and that they're not actually duped by media sensationalism. Sure. As long as you’re willing to see the flip side of that coin, where people put immediate faith in optimistic hot takes even when the it’s (unfortunately) a bunch of BS. There’s a lot of both scenarios going round.
|
|